MD, Head of Clinical Trials Department, Medical and Marketing Affairs, PLIVA Croatia Ltd., A member of TEVA Group
Mrs. Marijana Oremus is a medical doctor who worked in medical practice for more than eight years before joining the pharmaceutical industry. Working in the clinical trials area she has dealt with clinical projects of various complexities, being responsible for the whole project scope from developing the business case till clinical dossier finalization. As a head of clinical trials department she gained experience in coordination between relevant departments within the company regarding nomination, evaluation and selection of clinical projects as well as in people management, which represents a significant part of her responsibilities. Mrs Oremus interests are oriented to clinical trials working processes, systems improvements and innovations, focused mainly on phase IIIb and IV. By leading international, multicenter clinical trials her responsibility is to identify and utilize clinical support opportunities throughout the company, to create synergies between company’s clinical teams and other relevant departments as well as with medical professionals in the community. Following the recent changes in regulatory environment she is dealing with the development of risk management models in peri and post-approval safety surveillance projects, including the detection of critical points, to enable smooth and timely new product registration. Being a medical professional in the medical and marketing department, her role incorporates many additional activities regarding coordination and supervision of medical scope of work. These activities include selection of scientific conferences and congresses, preparation and organization of scientific programs for scientific symposia and workshops, development of medical platforms as a part of overall marketing strategies and campaigns, KOL management, communication and consultations towards Regulatory Agencies with regard to clinical issues, cross departmental collaboration regarding medical/clinical support for Registration, Pharmacovigilance, R&D and Biotechnology department.